» Articles » PMID: 38407670

Theranostics: a Multifaceted Approach Utilizing Nano-biomaterials

Overview
Journal Discov Nano
Date 2024 Feb 26
PMID 38407670
Authors
Affiliations
Soon will be listed here.
Abstract

Biomaterials play a vital role in targeting therapeutics. Over the years, several biomaterials have gained wide attention in the treatment and diagnosis of diseases. Scientists are trying to make more personalized treatments for different diseases, as well as discovering novel single agents that can be used for prognosis, medication administration, and keeping track of how a treatment works. Theranostics based on nano-biomaterials have higher sensitivity and specificity for disease management than conventional techniques. This review provides a concise overview of various biomaterials, including carbon-based materials like fullerenes, graphene, carbon nanotubes (CNTs), and carbon nanofibers, and their involvement in theranostics of different diseases. In addition, the involvement of imaging techniques for theranostics applications was overviewed. Theranostics is an emerging strategy that has great potential for enhancing the accuracy and efficacy of medicinal interventions. Despite the presence of obstacles such as disease heterogeneity, toxicity, reproducibility, uniformity, upscaling production, and regulatory hurdles, the field of medical research and development has great promise due to its ability to provide patients with personalised care, facilitate early identification, and enable focused treatment.

Citing Articles

Leveraging nature's nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications.

Chen Y, Douanne N, Wu T, Kaur I, Tsering T, Erzingatzian A Sci Adv. 2025; 11(9):eads5249.

PMID: 40009680 PMC: 11864201. DOI: 10.1126/sciadv.ads5249.


Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.

Rahman M, Jalouli M, Yadab M, Al-Zharani M Cancers (Basel). 2025; 17(4).

PMID: 40002294 PMC: 11852615. DOI: 10.3390/cancers17040701.


Advancements in Nanomedicine for the Diagnosis and Treatment of Kidney Stones.

Wang Y, Yang J, Amier Y, Yuan D, Xun Y, Yu X Int J Nanomedicine. 2025; 20:1401-1423.

PMID: 39925679 PMC: 11805677. DOI: 10.2147/IJN.S504318.


Nanobiomaterials & nanomedicine.

Arvejeh P J Transl Med. 2024; 22(1):1154.

PMID: 39731150 PMC: 11681672. DOI: 10.1186/s12967-024-06005-w.


Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology.

Hristova-Panusheva K, Xenodochidis C, Georgieva M, Krasteva N Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931344 PMC: 11206252. DOI: 10.3390/ph17060677.

References
1.
Chen Y, Tan C, Zhang H, Wang L . Two-dimensional graphene analogues for biomedical applications. Chem Soc Rev. 2014; 44(9):2681-701. DOI: 10.1039/c4cs00300d. View

2.
Kibria G, Hatakeyama H, Ohga N, Hida K, Harashima H . Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release. 2011; 153(2):141-8. DOI: 10.1016/j.jconrel.2011.03.012. View

3.
Peixoto R, Miranda-Vilela A, de Souza Filho J, Carneiro M, Oliveira R, Silva M . Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay. Tumour Biol. 2014; 36(5):3325-36. PMC: 4445484. DOI: 10.1007/s13277-014-2966-x. View

4.
Qin J, Peng Z, Li B, Ye K, Zhang Y, Yuan F . Gold nanorods as a theranostic platform for in vitro and in vivo imaging and photothermal therapy of inflammatory macrophages. Nanoscale. 2015; 7(33):13991-4001. DOI: 10.1039/c5nr02521d. View

5.
Ruman U, Fakurazi S, Masarudin M, Hussein M . Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. Int J Nanomedicine. 2020; 15:1437-1456. PMC: 7060777. DOI: 10.2147/IJN.S236927. View